Vaccines for Kids, a Global Surge in Cases, and More Coronavirus News

Vaccinating children spurs controversy, the Delta variant fuels a global surge, and drugmakers and countries consider boosters. Here’s what you should know:

Want to receive this weekly roundup and other coronavirus news? Sign up here!

Headlines

Vaccinating kids is poised to be the next politicized pandemic issue in the US

This week, Tennessee fired its top vaccine official for notifying health care providers of a long-standing legal mechanism that allows minors over 14 to be vaccinated without parental consent. The state has also stopped all online vaccination outreach to teens. This news, coupled with the CDC’s recent relaxation of guidelines for wearing masks inside school buildings, could well be an omen of the next big Covid controversy: vaccinating children. Clinical trials testing mRNA vaccines for kids are well underway, and first requests for emergency authorization are expected in September or October. But if they’re approved, shots for kids seem likely to become a political battleground rife with misinformation.

On Thursday, US surgeon general Vivek Murthy called misinformation about Covid-19 and vaccines more generally a pressing national concern, especially as vaccination rates have slowed and cases are once again on the rise. He called on tech companies in particular to make changes to their platforms to stop the spread of unfounded or inaccurate claims about the pandemic.

The Delta variant continues to spur a surge in cases around the world and in the US

click this link here now
blog link
Continue eading
Click Here
Clicking Here
Go Here
Going Here
Read This
Read More
Find Out More
Discover More
Learn More
Read More Here
Discover More Here
Learn More Here
Click This Link
Visit This Link
Homepage
Home Page
Visit Website
Website
Web Site
Get More Info
Get More Information
This Site
More Info
Check This Out
Look At This
Full Article
Full Report
Read Full Article
Read Full Report
a cool way to improve
a fantastic read
a knockout post
a replacement
a total noob
about his
active
additional hints
additional info
additional reading
additional resources
address
advice
agree with
anchor
anonymous
are speaking
article
article source
at bing
at yahoo
basics
best site
blog
bonuses
breaking news
browse around here
browse around these guys
browse around this site
browse around this web-site
browse around this website
browse this site
check
check here
check it out
check out here
check out the post right here
check out this site
check out your url
check over here
check these guys out
check this link right here now
check this out
check this site out
click
click for info
click for more
click for more info

Global outbreaks are worsening as the Delta variant continues to spread rapidly. The WHO reported that deaths in Africa rose by 43 percent in the last week, South Korea has tightened restrictions as it battles its worst outbreak yet, and Covid wards are overflowing in Indonesia, the world’s fourth-most-populous country. The surge is particularly bad in countries with lower vaccination rates, but fortunately some vaccine sharing efforts seem to be picking up speed. Late this week, for instance, Indonesia received 1.5 million doses of the Moderna vaccine following 3 million other American doses that arrived last weekend.

Delta is now also the dominant strain in the US, and case counts are going up in every state. In response to this surge, Los Angeles reinstated its indoor mask mandate for everyone—vaccinated or not.

Some countries weigh offering booster shots despite calls to prioritize first doses

Israel has started offering a third booster dose of the Pfizer-BioNTech vaccine to immunocompromised adults after the Delta variant sent case rates up again, even among people who have already been vaccinated. The country’s health minister said the decision on whether to make boosters more widely available is pending. Pfizer has been pitching boosters in the US as well, but senior US officials told the drugmaker that they would need more data on the efficacy of a third dose before approving it for use. Even so, a federal advisory panel is expected to meet next week to weigh the possibility of giving additional doses to patients with suppressed immunity.

Leave a Reply

Your email address will not be published. Required fields are marked *